Highpoint Pharmaceuticals LLC - Insider Trading & Ownership

Entity
Company
Location
16192 Coastal Highway, Lewes, Delaware
Summary
The estimated value of insider holdings of Highpoint Pharmaceuticals LLC is at least $489K dollars as of January 11, 2022. Highpoint Pharmaceuticals LLC is the 10%+ Owner of Hillstream BioPharma Inc. and owns shares of Tharimmune, Inc. (THAR) stock worth about $489K.
All Insider Reports
All Insider Reports

Ownership of Highpoint Pharmaceuticals LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
THAR Tharimmune, Inc. 10%+ Owner $489K Jan 11, 2022

There are no insider transactions reported by Highpoint Pharmaceuticals LLC